Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fradkin

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
JAMA|December 15, 1993
Risk of leukemia after treatment with pituitary growth hormoneJ E Fradkin, J L Mills, L B Schonberger, et al.
The Journal of Pediatrics|April 8, 2004
Long-term mortality in the United States cohort of pituitary-derived growth hormone recipientsJames L Mills, Lawrence B Schonberger, Diane K Wysowski, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2011
Lower risk of Creutzfeldt-Jakob disease in pituitary growth hormone recipients initiating treatment after 1977Joseph Y Abrams, Lawrence B Schonberger, Ermias D Belay, et al.
JAMA|February 20, 1991
Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United StatesJ E Fradkin, L B Schonberger, J L Mills, et al.
Diabetes Care|January 14, 2010
Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006Catherine C Cowie, Keith F Rust, Danita D Byrd-Holt, et al.
Circulation|June 29, 2005
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes MellitusPeter Libby, David M Nathan, Kristin Abraham, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
JAMA|December 15, 1993
Risk of leukemia after treatment with pituitary growth hormoneJ E Fradkin, J L Mills, L B Schonberger, et al.
The Journal of Pediatrics|April 8, 2004
Long-term mortality in the United States cohort of pituitary-derived growth hormone recipientsJames L Mills, Lawrence B Schonberger, Diane K Wysowski, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2011
Lower risk of Creutzfeldt-Jakob disease in pituitary growth hormone recipients initiating treatment after 1977Joseph Y Abrams, Lawrence B Schonberger, Ermias D Belay, et al.
JAMA|February 20, 1991
Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United StatesJ E Fradkin, L B Schonberger, J L Mills, et al.
Diabetes Care|January 14, 2010
Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006Catherine C Cowie, Keith F Rust, Danita D Byrd-Holt, et al.
Circulation|June 29, 2005
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes MellitusPeter Libby, David M Nathan, Kristin Abraham, et al.
Pageof 8